Home › Drug Codes › J Codes › J9179 · HALAVEN
Updated July 1st, 2026

HALAVEN J Code: J9179

Injection, eribulin mesylate, 0.1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9179, effective October 1, 2026: $63.972 per HCPCS billing unit, up 6.7% from $59.979. From CMS's final file.

?
Medicare Payment Limit ?
$59.979
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$59.979
/ HCPCS billing unit · APC 1426
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
11
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, eribulin mesylate, 0.1 mg
HCPCS Added Date January 1, 2012
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection | Solution

About HALAVEN

Halaven is a medication aligned to the HCPCS J Code: J9179 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: Eribulin is used to treat certain types of cancer (breast, liposarcoma). It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 11 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00143-9167-01 Eribulin Mesylate HIKMA PHARMACEUTICALS USA INC. 10 1 MG / 2 ML
00781-3391-94 Eribulin Mesylate Sandoz Inc 10 1 MG / 2 ML
10019-0080-01 Eribulin Mesylate Baxter Healthcare Company 10 1 MG / 2 ML
43598-0125-11 Eribulin Mesylate Dr. Reddys Laboratories Inc 10 1 MG / 2 ML
60505-6289-00 eribulin mesylate Apotex Corp. 10 1 MG / 2 ML
•••••-••••-•• Log in to view HALAVEN
HALAVEN
HALAVEN
Login to view 6 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

HALAVEN Pricing & Reimbursement

J9179 Private Payer Reimbursement
$80.77 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

HALAVEN Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 12.36%
Avg. Days to File 8.8days
Avg. Days to Pay 22.4days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9179 claims analytics on FocalPoint →
OnPoint Oncology

HALAVEN CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Halaven (J9179) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

HALAVEN Medically Unlikely Edits (MUE)

The most billing units of J9179 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.

Practitioner Office & Hospital Outpatient
50 units / day
= 5 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

HALAVEN Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Liposarcoma Metastatic Breast Cancer
Drug Class
Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Halaven billing and coding guide?
Billing and coding information for HALAVEN can be found through Eisai. Visit Here →
Are there any available Halaven patient assistance programs?
HALAVEN patient assistance information can be found through Eisai. Visit Here →
Where can I find Halaven prescribing information?
HALAVEN prescribing information can be found at the link below: Visit Here →
Where can I find Halaven side effect information?
Information regarding HALAVEN's side effects can be found at MedlinePlus Visit Here →
Does billing HALAVEN require JZ/JW wastage modifiers?
CMS has identified HALAVEN(J9179) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to HALAVEN.

J9264ABRAXANEInjection, paclitaxel protein-bound particles, 1 mgMultiple ManufacturersAdded January 1, 2006J9267PaclitaxelInjection, paclitaxel, 1 mgMultiple ManufacturersAdded January 1, 2015J9000ADRIAMYCINInjection, doxorubicin hydrochloride, 10 mgMultiple ManufacturersAdded January 1, 1984J9306PERJETAInjection, pertuzumab, 1 mgGenentechAdded January 1, 2014J9316PhesgoInjection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mgGenentechAdded January 1, 2021J9354KADCYLAInjection, ado-trastuzumab emtansine, 1 mgGenentechAdded January 1, 2014J9355HERCEPTINInjection, trastuzumab, excludes biosimilar, 10 mgGenentechAdded January 1, 2000J9356HERCEPTIN HYLECTAInjection, trastuzumab, 10 mg and hyaluronidase-oyskGenentechAdded July 1, 2019Q5112ONTRUZANTInjection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mgOrganonAdded July 1, 2019Q5113HERZUMAInjection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mgTevaAdded July 1, 2019